Valsartan/Sacubitril reduces mortality more than enalapril 10 mg twice daily in patients with heart failure

Mark H. Ebell

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)490-492
Number of pages3
JournalAmerican Family Physician
Volume91
Issue number7
StatePublished - Mar 1 2015
Externally publishedYes

Fingerprint

Enalapril
Heart Failure
Mortality
LCZ 696

ASJC Scopus subject areas

  • Family Practice

Cite this

Valsartan/Sacubitril reduces mortality more than enalapril 10 mg twice daily in patients with heart failure. / Ebell, Mark H.

In: American Family Physician, Vol. 91, No. 7, 01.03.2015, p. 490-492.

Research output: Contribution to journalArticle

@article{81c37fd8fbff437d851bea5f9365ce7b,
title = "Valsartan/Sacubitril reduces mortality more than enalapril 10 mg twice daily in patients with heart failure",
author = "Ebell, {Mark H.}",
year = "2015",
month = "3",
day = "1",
language = "English (US)",
volume = "91",
pages = "490--492",
journal = "American Family Physician",
issn = "0002-838X",
publisher = "American Academy of Family Physicians",
number = "7",

}

TY - JOUR

T1 - Valsartan/Sacubitril reduces mortality more than enalapril 10 mg twice daily in patients with heart failure

AU - Ebell, Mark H.

PY - 2015/3/1

Y1 - 2015/3/1

UR - http://www.scopus.com/inward/record.url?scp=84930724208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930724208&partnerID=8YFLogxK

M3 - Article

VL - 91

SP - 490

EP - 492

JO - American Family Physician

JF - American Family Physician

SN - 0002-838X

IS - 7

ER -